The high expression of UBE2S in ovarian cancer was related with lymph node metastasis and platinum resistance, but not with age, FIGO staging, CA125 level, and peritoneal metastasis. Here, UBE2S is linked to metastatic malignant neoplasm in the lymph nodes.